Jianying Zhang to Neoplasms
This is a "connection" page, showing publications Jianying Zhang has written about Neoplasms.
Connection Strength
1.296
-
Zhang J, Zhang B, Zhang Y. Cancer Immunology and Cancer Immunodiagnosis 2016. J Immunol Res. 2017; 2017:9127382.
Score: 0.283
-
Zhu Q, Han SX, Zhou CY, Cai MJ, Dai LP, Zhang JY. Autoimmune response to PARP and BRCA1/BRCA2 in cancer. Oncotarget. 2015 May 10; 6(13):11575-84.
Score: 0.252
-
Zhu Q, Liu M, Dai L, Ying X, Ye H, Zhou Y, Han S, Zhang JY. Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis. Autoimmun Rev. 2013 Oct; 12(12):1123-8.
Score: 0.221
-
Zhang JY, Looi KS, Tan EM. Identification of tumor-associated antigens as diagnostic and predictive biomarkers in cancer. Methods Mol Biol. 2009; 520:1-10.
Score: 0.162
-
Looi K, Megliorino R, Shi FD, Peng XX, Chen Y, Zhang JY. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies. Oncol Rep. 2006 Nov; 16(5):1105-10.
Score: 0.140
-
Megliorino R, Shi FD, Peng XX, Wang X, Chan EK, Tan EM, Zhang JY. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection. Cancer Detect Prev. 2005; 29(3):241-8.
Score: 0.123
-
Zhang JY. Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis. Cancer Detect Prev. 2004; 28(2):114-8.
Score: 0.115